Safety and efficacy of sorafenib for the treatment of recurrent hepatocellular carcinoma after liver transplantation.
about
Liver transplantation for hepatocellular carcinoma beyond the Milan criteria: A reviewHepatocellular Carcinoma and Liver Transplantation: State of the ArtMultidisciplinary perspective of hepatocellular carcinoma: A Pacific Northwest experience.Thrombocytopenia for prediction of hepatocellular carcinoma recurrence: Systematic review and meta-analysisEvolving role of Sorafenib in the management of hepatocellular carcinoma.Peri-operative use of sorafenib in liver transplantation: a time-to-event meta-analysisManagements of recurrent hepatocellular carcinoma after liver transplantation: A systematic review.The clinical effect and relevant mechanism of combined sorafenib and radiofrequency ablation in the treatment of early small hepatocellular carcinomaHepatocellular carcinoma cases with high levels of c-Raf-1 expression may benefit from postoperative adjuvant sorafenib after hepatic resection even with high risk of recurrence.Sorafenib use in the transplant setting.Cutaneous Metastases from Primary Hepatobiliary Tumors as the First Sign of Tumor Recurrence following Liver Transplantation.The role of metronomic capecitabine for treatment of recurrent hepatocellular carcinoma after liver transplantation.Management of pediatric hepatocellular carcinoma: A multimodal approach.Role of Sorafenib in Patients With Recurrent Hepatocellular Carcinoma After Liver Transplantation.
P2860
Q26750463-676C72C6-A024-42F8-9E3B-83753290C984Q26781798-66C9CC92-939A-4C77-83CC-FD1CD65D96C4Q26998606-D85D3B74-76E6-4768-9F15-7B029DBA8DE4Q26998730-29F1FB6D-AF20-4FA0-B53A-C9D4EFD012C4Q33779864-02BB25F2-16F2-44A9-9FB1-C21D229339E5Q35045805-375CC2D7-4367-4581-B878-8C6AA9CECFA6Q35818336-8578835C-32FB-4B81-82FE-0CB193D2B8C3Q37108804-37A003C6-F5D7-431D-8B6A-2B5EE1D61C28Q37520635-71B747A3-E8C9-47ED-9E47-EB752123D5A1Q38210270-3C1D0DFF-7391-427B-9776-010A712F764BQ38239684-01EE1EA2-3EBC-4FCE-BE38-485230E32E3FQ41199454-2FFCA701-5CF5-4382-B146-672CE7C4FA4AQ48252418-028237F0-C0DB-4366-A98A-205F431E6B3FQ51840523-B95C0F12-6EEC-4149-B656-8341E1FB85CA
P2860
Safety and efficacy of sorafenib for the treatment of recurrent hepatocellular carcinoma after liver transplantation.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Safety and efficacy of sorafen ...... a after liver transplantation.
@ast
Safety and efficacy of sorafen ...... a after liver transplantation.
@en
type
label
Safety and efficacy of sorafen ...... a after liver transplantation.
@ast
Safety and efficacy of sorafen ...... a after liver transplantation.
@en
prefLabel
Safety and efficacy of sorafen ...... a after liver transplantation.
@ast
Safety and efficacy of sorafen ...... a after liver transplantation.
@en
P2093
P2860
P356
P1476
Safety and efficacy of sorafen ...... a after liver transplantation.
@en
P2093
Abhijeet Waghray
Bassam Estfan
Bengi Balci
Carlos Romero-Marrero
Federico Aucejo
Galal El-Gazzaz
K V Narayanan Menon
Richard Kim
Robert Pelley
P2860
P304
P356
10.1111/CTR.12150
P577
2013-06-13T00:00:00Z